Literature DB >> 299902

The effectiveness of topical cardiac hypothermia.

Q R Stiles, R K Hughes, G G Lindesmith.   

Abstract

The effectiveness of cooling the subendocardial myocardium by five different methods was evaluated in a group of 100 patients. The most effective and consistent method to cool the heart was by total body hypothermia with the heat exchanger in the cardiopulmonary bypass system. Myocardial temperature became equal to vena caval blood temperature after only a one minute lag. The least effective methods of myocardial cooling were those in which a bath of chilled fluid enveloped the outside surface of the heart, with and without aortic cross-clamping. The drop in ventricular septal temperature was so small that topical hypothermia, by itself, may be worthless. Two methods in wich chilled fluid was perfused through the coronary system produced a significant lowering of myocardial temperature. One of these methods employs coronary perfusion with a cold cardioplegic solution in addition to total body hypothermia. It is our current choice for myocardial protection during cross-clamping of the ascending aorta.

Entities:  

Mesh:

Year:  1977        PMID: 299902

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  Retrograde coronary sinus perfusion for myocardial protection.

Authors:  X P Fu; H J Lan
Journal:  J Tongji Med Univ       Date:  1988

2.  Laboratory and initial clinical studies of nifedipine, a calcium antagonist for improved myocardial preservation.

Authors:  R E Clark; I Y Christlieb; T B Ferguson; C S Weldon; J P Marbarger; B E Sobel; R Roberts; P D Henry; P A Ludbrook; D Biello; B K Clark
Journal:  Ann Surg       Date:  1981-06       Impact factor: 12.969

3.  Preoperative Topical Hypothermia used in Prolonged Severe Lower Limb Ischemia to Avoid Ischemic Damage - The First Clinical Experience.

Authors:  Claes Forsell; Jonas Aberg; Zoltán Szabó
Journal:  Int J Biomed Sci       Date:  2013-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.